Skip to content

Can kava cause tardive dyskinesia? Understanding the neurological risks

4 min read

Case reports and studies have linked chronic or heavy kava use to adverse neurological effects, including abnormal body movements, leading to concerns about conditions like tardive dyskinesia. The relationship between the herbal supplement kava and movement disorders is complex, involving its interaction with the brain's dopamine pathways. So, can kava cause tardive dyskinesia, and what are the known risks?

Quick Summary

Kava's interaction with the brain's dopamine system can cause movement disorders and exacerbate conditions like Parkinson's disease. While not a direct cause of classical tardive dyskinesia from antipsychotics, kava can induce dyskinetic movements or increase susceptibility in vulnerable individuals.

Key Points

  • Dopamine System Interaction: Kava's active compounds, kavalactones, interfere with dopamine signaling, a key neurotransmitter in motor control, linking it to potential movement disorders.

  • Not Classic Tardive Dyskinesia: Kava does not cause classical tardive dyskinesia (TD) in the same way as chronic antipsychotic use, but it can induce dyskinetic movements or exacerbate other movement disorders.

  • Extrapyramidal Side Effects: Chronic or heavy kava use has been linked to various extrapyramidal effects, including tremors, oral dyskinesia, and rare cases of severe choreoathetosis.

  • Drug Interactions: Kava should not be combined with antipsychotic medications, anti-Parkinson's drugs (like levodopa), or other CNS depressants due to increased risk of side effects.

  • Considerable Health Risks: In addition to neurological issues, kava use carries significant risks of liver toxicity, and the FDA has issued warnings about the risk of severe liver injury.

In This Article

The Neurological Effects of Kava

Kava, derived from the root of the Piper methysticum plant, is traditionally used for its calming and sedative effects. These effects are attributed to its active compounds, known as kavalactones, which interact with the central nervous system. The precise mechanism is not fully understood, but it involves modulation of several neurotransmitter systems, including the gamma-aminobutyric acid (GABA) system and, crucially, the dopamine system.

Kava's Impact on Dopamine

Dopamine is a key neurotransmitter involved in motor control, reward, and motivation. The development of tardive dyskinesia (TD) is strongly linked to long-term use of medications that block dopamine D2 receptors, such as older antipsychotics. Kava's interference with dopamine signaling is a primary reason for concern regarding movement disorders. Research shows that certain kavalactones can affect dopamine levels in the brain's reward centers. Specifically, some studies suggest kavalactones inhibit the reuptake of dopamine, increasing its availability in the synapse, which can lead to dysregulated motor function.

Case Reports and Evidence of Kava-Induced Dyskinesia

Numerous case reports and clinical observations have documented movement-related side effects following kava consumption. These extrapyramidal symptoms are similar to those caused by antipsychotic medications, indicating a shared impact on the brain's motor pathways.

  • Oral Dyskinesia: Reports have documented oral dyskinesia, characterized by involuntary, repetitive movements of the face, tongue, and jaw, even with short-term kava use.
  • Worsening of Parkinson's Disease: Since kava can interfere with dopamine, it is contraindicated in individuals with Parkinson's disease, a condition characterized by dopamine deficiency. It can counteract the effects of L-dopa medication and worsen tremors and other motor symptoms.
  • Choreoathetosis: Rare but severe cases of choreoathetosis—a combination of involuntary, jerky movements (chorea) and slow, writhing movements (athetosis)—have been reported in heavy kava users.
  • Drug Interactions: Kava should not be combined with antipsychotic medications, as it can worsen neurological side effects or potentially trigger dystonic reactions.

Comparing Kava-Induced Movement Disorders and Tardive Dyskinesia

While kava can cause movement disorders, it is important to distinguish them from classical tardive dyskinesia (TD), which is a specific, often irreversible, late-onset side effect of certain dopamine-blocking drugs. Kava-induced movements are typically reversible upon cessation of use, whereas TD can persist long after the offending medication is stopped. However, the underlying pathological link—dopamine system dysregulation—is a common factor.

Feature Kava-Induced Movement Disorder Classical Tardive Dyskinesia
Primary Cause Kavalactone-induced dopamine modulation Long-term use of dopamine-blocking antipsychotics
Mechanism Inhibition of dopamine reuptake; overall dopamine system interference Dopamine D2 receptor supersensitivity following chronic blockade
Onset Can occur with short-term or chronic use Typically develops after months or years of medication use
Reversibility Often reversible upon discontinuation of kava Can be irreversible even after stopping the medication
Symptoms Oral dyskinesia, choreoathetosis, tremors, worsening of Parkinsonism Involuntary movements (face, tongue, limbs), grimacing, blinking

Factors Increasing Risk

Several factors can increase an individual's risk of experiencing kava-induced movement disorders:

  • High Dose or Chronic Use: Consuming high doses or using kava for long periods increases the risk of extrapyramidal and other neurological effects.
  • Genetic Predisposition: A family history of movement disorders, such as essential tremor, or genetic susceptibility can increase vulnerability.
  • Concurrent Medication Use: Combining kava with other central nervous system depressants, including antipsychotics, can significantly increase the risk of adverse reactions.
  • Specific Kava Preparations: The method of preparation and concentration of kavalactones may influence the risk profile, with some commercial extracts potentially carrying a higher risk than traditional water-based preparations.

Potential for Serious Health Consequences

Beyond movement disorders, kava carries other serious health risks that should not be overlooked. The most significant is liver toxicity, with multiple reports of hepatitis, cirrhosis, and liver failure linked to kava products. The U.S. Food and Drug Administration (FDA) has issued warnings regarding severe liver injury associated with kava use.

Additional Adverse Effects

  • Kava Dermopathy: A scaly, dry, or yellowish rash that affects the skin, commonly seen with chronic, heavy kava consumption.
  • Exacerbation of Mental Illness: Kava can worsen symptoms of pre-existing mental health conditions, including anxiety and schizophrenia.
  • Impaired Cognitive and Motor Skills: Higher doses can lead to sedation, muscle weakness, and impaired motor reflexes, making activities like driving unsafe.

Who Should Avoid Kava?

Given the potential for serious side effects, medical experts recommend that certain individuals avoid kava entirely. This includes:

  • People with a history of liver disease or those taking hepatotoxic medications.
  • Individuals with Parkinson's disease or other pre-existing movement disorders.
  • Patients on antipsychotic medications or other CNS depressants.
  • Pregnant or nursing women.

Conclusion: Navigating the Risks

While can kava cause tardive dyskinesia is a complex question, the answer is a qualified 'no' in the classical sense, but an emphatic 'yes' to the risk of causing other significant movement disorders. Kava's effect on the dopamine system is well-documented and forms the basis for its potential to induce dyskinetic movements, exacerbate existing conditions like Parkinson's disease, and interact dangerously with certain medications. The risk is elevated with high doses, chronic use, and in susceptible individuals. Therefore, before considering kava for any purpose, it is essential to consult a healthcare professional to weigh the risks against the potential benefits, especially given the availability of safer, more effective alternatives for conditions like anxiety.

For more information on the FDA's warnings and potential risks associated with kava, see the Consumer Advisory for Dietary Supplements Containing Kava.

Frequently Asked Questions

No, kava does not typically cause classic tardive dyskinesia (TD), which is a specific, often irreversible movement disorder associated with long-term use of dopamine-blocking antipsychotic medications. However, kava's effects on the dopamine system can cause other, similar movement disorders.

Kava can cause a range of extrapyramidal symptoms, including oral dyskinesia (involuntary movements of the mouth and face), tremors, and in rare, severe cases, choreoathetosis (jerky and writhing movements).

Kava's kavalactones interfere with the brain's dopamine signaling by inhibiting its reuptake and affecting dopamine levels in certain brain regions, which can lead to dysregulation of motor control.

Yes, kava can worsen the symptoms of Parkinson's disease. By interfering with dopamine, it can counteract the effects of dopaminergic medications like levodopa and exacerbate tremors and other movement-related symptoms.

No, kava should not be taken with antipsychotic medications. This combination can increase the risk of neurological side effects, including sudden abnormal movements known as dystonic reactions.

Yes, unlike classical tardive dyskinesia, the movement disorders induced by kava are generally reversible and tend to resolve after discontinuing its use.

The most serious risk associated with kava is severe liver toxicity, including hepatitis and liver failure, which has prompted warnings from the FDA. Long-term use is also linked to kava dermopathy (scaly skin) and can worsen mental health conditions.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.